DRKS00015435尚未招募不适用
Detection of potential biomarkers CXCL9, CXCL10, CCL2, CCL 5, IL-37 and IL-38 in blood and urine for acute and chronic rejection after kidney transplantation
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main0 个研究点目标入组 250 人开始时间: 2018年11月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Men and women over the age of 18, who receive a kidney allograft and have no signs for rejection. The earliest inclusion date is four weeks after kidney transplantation.
- •Men and women over the age of 18, who receive a kidney allograft and have a rejection, which is confirmed by a kidney biopsy
- •Men and women over the age of 18, who receive a kidney allograft and suffer from a CMV- or BKV-infection
- •Men and women over the age of 18, after de novo kidney transplantation
- •Healthy men and healthy women over the age of 18, who don’t receive a kidney allograft
排除标准
- •exclusion criteria arise from inclusion criteria
研究者
相似试验
已完成
不适用
Identification of biomarkers that correlate with clinical features and outcomes following concussioACTRN12615000543583The University of Western Australia80
招募中
不适用
Research to find new indicators for diagnosis and treatment of bladder cancer using exosomes in urinebladder cancerJPRN-UMIN000045726St.Marianna University School of Medicine420
尚未招募
不适用
Establishment of new diagnostic Biomarker and Characterization of protective bone marrow niche in patients with multiple myelomaC90Multiple myeloma and malignant plasma cell neoplasmsDRKS00010830niversitätsklinikum Freiburg160
招募中
不适用
Identification of biomarkers for diagnosis and prognosis in the patients with obstructive sleep apneaobstructive sleep apneaJPRN-UMIN000021503Osaka university graduate School of medicine The department of geriatric and general medicine200
招募中
不适用
Explore for biomarkers that are useful for detection of gastrointestinal cancer and prediction of therapeutic response of gastrointestinal cancer by analyzing circulating tumor DNA (ctDNA) and circulating tumor cells (CTC)Gastrointestinal cancer (esophageal cancer, stomach cancer, colorectal cancer)JPRN-UMIN000017372Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences200